Kompatscher A, de Baaij JH, Aboudehen K, Farahani S, van Son LH, Milatz S, Himmerkus N, Veenstra GC, Bindels RJ, Hoenderop JG. Transcription factor HNF1␤ regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney.
INTRODUCTION
Autosomal dominant tubulointerstitial kidney disease-hepatocyte nuclear factor 1 homeobox ␤ [ADTKD-HNF1␤, Online Mendelian Inheritance in Man (OMIM): 137920] is caused by the deletion of or heterozygous mutations in HNF1␤ (34, 39) . Patients suffer from a complex and heterogeneous phenotype characterized by renal malformations and maturity-onset diabetes of the young subtype 5 (MODY5) (1-3, 34, 39, 47) . Interestingly,~50% of ADTKD-HNF1␤ patients experience impaired renal electrolyte handling resulting in hypomagnesemia, hypokalemia, and hypocalciuria (1, 13, 46, 47) .
HNF1␤ is ubiquitously expressed in the epithelial cells of all nephron segments (14) . In the distal convoluted tubule (DCT), HNF1␤ regulates the expression of the Kir4.1-Kir5.1 K ϩ channel and the ␥-subunit of the Na ϩ -K ϩ -ATPase (FXYD2) (23, 36) . Kidney-specific (Ksp) HNF1␤ knockout (KO) mice display reduced Kcnj10 (Kir4.1) and Kcnj16 (Kir5.1) expression levels, resulting in lower Na ϩ -Cl Ϫ -cotransporter (NCC) transcript levels (15) . These findings explain why ADTKD-HNF1␤ resembles Gitelman syndrome (OMIM: 263800), with seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance; or epilepsy, ataxia, sensorineural deafness, and renal tubulopathy (SeSAME-EAST; OMIM: 612780); or isolated dominant hypomagnesemia (IDH; OMIM: 15040). These are caused by NCC, Kir4.1, and FXYD2 mutations, respectively (5, 16, 26) .
HNF1␤ is ubiquitously expressed along the nephron, including the thick ascending limb of Henle's loop (TAL). Here, HNF1␤ regulates the expression of uromodulin (UMOD), which is a cystic disease gene responsible for ADTKD-UMOD (OMIM: 191845) (30) . The TAL plays a dominant role in Na ϩ , Ca 2ϩ , and Mg 2ϩ reabsorption (17, 36) . In this segment, the furosemide-sensitive Na ϩ -K ϩ -2Cl Ϫ -cotransporter (NKCC2) facilitates transcellular Na ϩ reabsorption. A strong lumenpositive potential drives the paracellular transport of divalent cations, which is maintained by the paracellular backflow of Na ϩ and the recycling of K ϩ into the lumen by the renal outer medullary potassium channel. A highly regulated tight junction complex consisting of claudins 3, 14, 16, and 19 forms a pore to facilitate the paracellular reabsorption of Ca 2ϩ and Mg 2ϩ . The ion permeability and selectivity of this tight junction complex depend on the particular expression of each of the claudin subunits (29, 42) . Whereas claudins 16 and 19 are cation-permeable, claudin 14 is generally considered cationblocking, shifting the preference of the claudin 16 -19 pore to Na ϩ instead of Ca 2ϩ and Mg 2ϩ . Over the last few years, the calcium-sensing receptor (CaSR) was identified as regulator of the claudin complex (28, 29) . Several studies described the role of the CaSR in electrolyte transport in the TAL (24, 28 , and reduced levels of these ions in the urine (31) . Recent research shows how CaSR activation regulates claudin expression, by initiating a cellular cascade that results in the decreased expression of two specific microRNAs, Mir-9 and Mir-374, which, in turn, raise claudin 14 protein levels (18, 28, 29) . As a consequence, Ca 2ϩ and Mg 2ϩ reabsorption in the TAL is decreased, which was observed in mice treated with the CaSR-agonist cinacalcet (28) .
Although HNF1␤ is highly expressed in the TAL, the role of HNF1␤ in electrolyte reabsorption in this segment has never been examined. The aim of the present study was to investigate the function of HNF1␤ in the TAL. The CaSR was identified as a prime candidate for HNF1␤ transcriptional regulation by screening HNF1␤ chromatin immunoprecipitation and sequencing (ChIP-seq) data. Transcriptional regulation of the CaSR by HNF1␤ was assessed by luciferase assays and siRNA knockdown experiments in MKTAL cells. Quantitative PCR analysis was performed on HNF1␤ mutant mice kidney tissue to determine differences in Casr expression in vivo.
MATERIALS AND METHODS
Cell lines. Human embryonic kidney 293 (HEK293) cells were grown in DMEM (Lonza, Leusden, The Netherlands) containing 10% (vol/vol) FCS and 2 mM L-glutamine, at 37°C in a humidity-controlled incubator with 5% (vol/vol) CO 2. The immortalized mouse kidney TAL cell line (MKTAL) was derived from microdissected medullary TAL tubules (6) . MKTAL cells were cultured in DMEM/ HAM-F12 (1:1) (Lonza) containing 5% (vol/vol) FCS and 2 mM L-glutamine, at 37°C in a humidity-controlled incubator with 5% (vol/vol) CO 2 (6) .
Animal experimentation. Renal inactivation of HNF1␤ was achieved using Cre/LoxP recombination by crossing Ksp-cadherin Cre mice with HNF1␤ flox/flox (30) . Cre/LoxP activity varies along the nephron and ensured HNF1␤ inactivation along 27% of the proximal tubule, 99% of the TAL, 92% of the DCT/connecting tubule, and 100% of the collecting duct (38) . Mice were housed in standard cages with bedding material consisting of straw and paper in a temperatureand light-controlled room, with standard pellet chow and deionized drinking water available ad libitum. Animals were euthanized at postnatal day 28. An equal number of male and female mice were used for all procedures. All animal procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committees of the University of Texas Southwestern Medical Center and the University of Minnesota Medical School. The animal protocol number is 1503-32434.
Immunohistochemistry. Immunohistochemistry (IHC) was performed as previously described (36) . In short, stainings for HNF1␤ were achieved on 4-m sections of mouse kidney samples fixed in formalin and embedded in paraffin. Sections were incubated for 1 h at 4°C in rabbit anti-HNF1␤ (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:1,000 and mouse anti-Tamm-Horsfall at 1:2,000 (Santa Cruz Biotechnology). For detection, samples were incubated with an Alexa Fluor 594-conjugated goat anti-mouse antibody 1:300 (Thermo Scientific, Amsterdam, The Netherlands) and a biotin-conjugated swine anti-rabbit antibody 1:2,000. Subsequently, samples were incubated with streptavidin-horseradish peroxidase (HRP) 1:100 and fluorescein-tyramide 1:50 using the TSA Fluorescein System (PerkinElmer, Groningen, The Netherlands). Cell nuclei were stained with DAPI-Fluoromount-G mounting medium (Southern Biotech, Uithoorn, The Netherlands) at room temperature for 5 min. Images were taken with an AxioCam MRm camera (Zeiss, Sliedrecht, The Netherlands) at ϫ40 magnification. Zeiss Zen 2012 (Zeiss) software was used to acquire the images.
Cloning. The human CaSR promoter 1 region (Ϫ2622 bp, Ϫ539 bp upstream) from the transcription start site (TSS) and the CaSR promoter 2 region (Ϫ972 bp, Ϫ242 bp upstream) were amplified from a human bacterial artificial chromosome (BAC) clone (Human RPCI-11.c 79M2; chr3: 121,868,424 -122,055,369; Source Biosciences, Nottingham, UK) using a high-fidelity DNA polymerase (Phusion, Thermo Fisher, Amsterdam, The Netherlands). The HNF1␤ binding site region (ϩ16,290 bp to ϩ16,864 bp) was amplified from the same human BAC clone. The CaSR promoter 1 and promoter 2 PCR products were digested with restriction enzymes KpnI and NheI, whereas the HNF1␤ binding region was digested with NheI and XhoI (New England BioLabs, Leiden, The Netherlands). The CaSR promoter sequences were ligated first into the pGL3b vector, followed by the HNF1␤ binding region. Both sequences were cloned upstream of the luciferase gene using T4 DNA ligase (New England BioLabs). Primers used for the CaSR promoter 1 region were forward 5=-TAAAGCTTCTAGCCACAGCG-3= and reverse 5=-CTCATTCTG-CAAGACTCAGGTC-3=. The following primers were used for the CaSR promoter 2 PCR: forward 5=-TAAGAGTTTGGGCACGCG-3= and reverse 5=-GTTCCCCGGTCCTACCTG-3=. For the HNF1␤ binding region, the subsequent primers were used: forward 5=-GAAGCACAGATTATTACGGAGATCTC-3= and reverse 5=-CAT-GTCCCTGACCTAATTTGAG-3=. Human HNF1␤ full-length cDNA was amplified by PCR from HNF1␤ pCMV-SPORT6 (clone IRATp-970A0421D), ImaGenes) and subcloned into the pCINeo IRES GFP expression vector. HNF1␤ p.Lys156Glu was obtained by site-directed mutagenesis (Stratagene, La Jolla, CA) (22) .
Luciferase assay. HEK293 cells were transiently transfected with 700 ng of the promoter firefly luciferase constructs using polyethylenimine cationic polymer (PEI) (Invitrogen, Breda, The Netherlands) (ratio 1 g DNA to 6 l PEI). Cells were transfected with either a pGL3b-empty, pGL3b-hCaSR-promoter-1, pGL3b-hCaSRpromoter-2, pGL3b-hCaSR-promoter-1, or a pGL3b-hCaSR-promoter-2-HNF1␤-binding-region construct. All three conditions were additionally transfected with 50 ng of the pCINEO-empty, pCINEOhHNF1␤, or pCINEO-hHNF1␤ p.Lys156Glu mutant construct. In the case of the CaSR promoter 2 experiments, only pCINEO-empty and pCINEO-hHNF1␤ constructs were used. For standardization of the transfection efficiency, 20 ng of Renilla luciferase plasmid pRL under a Human cytomegalovirus promoter (CMV) was used as a reference in all conditions. Firefly and Renilla luciferase activities were measured with the dual-luciferase reporter assay (Promega, Fitchburg, MA).
Real-time quantitative PCR. MKTAL cells were transiently transfected with 100 pmol of a siRNA smart pool against Hnf1␤ (Dharmacon, Lafayette, CO) (44) . Cells were transfected using Lipofectamine 2000 (Invitrogen, Breda, The Netherlands) adding 3 l for each condition. After 48 h, total RNA isolation was performed with TRIzol (Invitrogen, Breda, The Netherlands). 1.5 g of RNA was used for reverse transcription using a Moloney murine leukemia virus reverse transcriptase protocol, as described by the manufacturer (Invitrogen). The cDNA was used to determine mRNA expression levels by CF96 real-time PCR detection system (Bio-Rad, Veenendaal, The Netherlands) for target genes of interest and of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (Gapdh) as an endogenous control. RT-quantitative PCR (qPCR) primers are reported in Table 1 .
Ussing chamber. After seeding MKTAL cells on transwell membranes, we monitored confluence by measuring transepithelial electrical resistance (TEER) daily with an EVOM 2 chamber (World Precision Instruments, Sarasota, FL). MKTAL cells were transfected with 100 pmol siRNA for 24 h, a day before these cells reached their TEER plateau (30 -40 ⍀·cm 2 ). Measurements in the Ussing chamber were performed 24 h after transfection of the MKTAL cells. Experimental and control solutions were preheated to 37°C before pouring them in liquid reservoirs connected to the Ussing chamber. Two additional heaters were interposed between the fluid reservoirs and the chamber. The flow rate was~10 ml/min. Transepithelial voltage was recorded using agar bridges [2.5 (wt/vol) agar in 1 M KCl] and chlorinated silver electrodes connected to an Ussing-Amplifier UPG3 A 10-A current pulse was applied every 10 s, and the resulting voltage reflection was used to calculate transepithelial resistance according to Ohm's law. Paracellular permeability properties were assessed by generating a NaCl diffusion potential reducing the NaCl concentration to 30 mM first at the apical, and then on the basolateral side and by generating bi-ionic diffusion potentials replacing NaCl by either MgCl2 or CaCl2. All three permeability ratios PNa/PCl, PMg/PNa, and PCa/PNa were calculated with the Goldman-Hodgkin-Katz equation and a simplified Kimizuka-Koketsu equation, respectively (37, 43) . Osmolality for all solutions was~300 mosmol/kg H2O, and pH was set at 7.4 using HCl. The composition of the solutions used was the following: Ringer's solution (control solution) in mM: 145 NaCl, 0. Real-time qPCR on Ksp-Cre;Hnf1␤ flox/flox kidneys. Total RNA from postnatal day 28 adult wild-type or HNF1␤ mutant mouse kidneys was extracted using the RNeasy mini kit (Qiagen, Germantown, MD), according to the manufacturer's protocol. RNA was treated with DNase (Invitrogen), and cDNA was synthesized using superscript III first-strand synthesis kit (Invitrogen). cDNA was diluted 1:20, and 10 l was used in the RT-qPCR reaction. RT-qPCR was performed with the iTAG Universal SYBR Green Supermix (Bio-Rad) using the CFX Connect Real-Time System (Bio-Rad). U6 spliceosomal RNA was used as an endogenous control. RT-qPCR primers are listed in Table 1 .
Chromatin-immunoprecipitation and quantitative PCR. Chromatin was isolated from an immortalized DCT cell line (mpkDCT4a) cells by fixing with 1% (vol/vol) formaldehyde (Ultra-Pure) (Thermo Scientific) for 15 min at RT. Cells were washed and permeabilized in 0.25% (vol/vol) Triton-X-100 and 0.05% (vol/vol) SDS. Samples were sonicated in a Diagenode Bioruptor (Diagenode, Ougrée, Belgium) 50 times, 30 s on 30 s off, at high intensity. Chromatin samples were then immunoprecipitated with Protein A/G beads (Santa Cruz Biotechnology) in 5 g rabbit anti-HNF1␤ (Santa Cruz Biotechnology, Santa Cruz, CA) for 16 h at 4°C. Samples were de-cross-linked in 5 M NaCl at 65°C for 5 h. De-cross-linked samples were then purified with phenol-chloroform. cDNA was synthesized from isolated RNA, and RT-qPCR was performed as described above. Primers targeting the HNF1␤ binding sites found in the Casr and Pkhd1 gene are represented in Table 1 .
Data analysis. All results presented are based on at least three independent experiments. Values are expressed as means Ϯ SE. Statistical significance (P Ͻ 0.05) was determined using one-tailed Students t-test or one-way ANOVA with Dunnett's multiple-comparison procedure. ChIP-seq data can be accessed through NCBI GEO (accession no.: GSE77397).
RESULTS

Expression of HNF1␤ in the TAL.
Immunohistochemistry was performed on mouse kidney slices to investigate HNF1␤ expression and localization in the TAL. HNF1␤ localizes to the nuclei of tubular cells and is coexpressed with the TALspecific marker uromodulin (Fig. 1) .
HNF1␤ regulates the expression of the calcium-sensing receptor. Analysis of previously published HNF1␤ ChIP-seq data in an immortalized mouse DCT cell line revealed a highly enriched binding site for HNF1␤ in the second intron of the Casr gene ( Fig. 2A) (36) . The binding site is located ϩ16,611 nucleotides from the Casr TSS and displays elevated nucleotide conservation (Fig. 2B) . The binding site has a motif conservation score of 6.38 as calculated by the screen motif algorithm, indicating high conservation and placing it in the top 5% of most conserved HNF1␤ peaks (n ϭ 7421) found in the HNF1␤ ChIP-seq data set (36, 40) . Reproducibility of this binding site was validated by performing chromatin-immunoprecipitation and quantitative PCR (ChIP-RT-qPCR), resulting in a 24-fold enrichment over the genomic background, which was comparable to the HNF1␤ binding site in the fibrocystin Table 1 . RT-quantitative PCR primer sequences
Casr, calcium-sensing receptor; Cldn16, claudin 16; Cldn19, claudin 19; Cldn10b, claudin 10b; Cldn14, claudin 14; Hnf1␤, hepatocyte nuclear factor 1 homeobox ␤; Cldn3, claudin 3; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; Kcnj16, ATP-sensitive inward rectifier potassium channel 16; Kcnj16, ATP-sensitive inward rectifier potassium channel 16; Pkhd1 (chIP), fibrocystin precursor; U6, U6 spliceosomal RNA.
precursor (Pkhd1) gene that was used as a positive control (Fig.  2C) . Subsequently, luciferase assays were performed on HEK293 cells containing the human promoter for the CaSR, including the HNF1␤ binding site. HNF1␤ overexpression raised promoter activity significantly by 5.8-fold (P Ͻ 0.05) compared with cells that lacked HNF1␤ expression (Fig. 2D) . Overexpression of the HNF1␤ p.Lys156Glu mutant that was previously reported in a patient with renal cysts and MODY, abolished the rise in promoter activity (1, 19) . No significant changes were observed in mock-transfected cells. Luciferase experiments with the alternative CaSR promoter 2 did not show HNF1␤-induced CaSR transcription (Fig. 2E) . Removal of the HNF1␤ binding site abolishes any significant HNF1␤-induced increase in CaSR promoter activity (Fig. 2C) .
siRNA-mediated knockdown of HNF1␤ downregulates Casr and Cldn14 and upregulates Cldn10b transcript levels in vitro.
To further elucidate the role of HNF1␤ in the transcriptional regulation of the CaSR, MKTAL cells were transfected with siRNA targeting HNF1␤. RT-qPCR analysis revealed a significant decrease of 59 Ϯ 11% in Hnf1␤ transcript levels compared with nontargeting siRNA-transfected cells (Fig. 3A) . A similar significant decrease of 56 Ϯ 18% was observed for the Casr (Fig. 3B) . Kcnj16 mRNA levels were taken along as a positive control. As expected, Kcnj16 transcript levels were significantly decreased by 65 Ϯ 19% (Fig. 3C) (36) . In addition, mRNA levels of Cldn3, Cldn10b, Cldn16, Cldn19, and Cldn14 were investigated, as these tight junction proteins are involved in the reabsorption of Ca 2ϩ and Mg 2ϩ in the TAL. Transcript levels of Cldn14 were significantly downregulated by 48 Ϯ 14% (Fig. 3F) . However, no significant changes were found in the abundances of Cldn16, Cldn19 and Cldn3 mRNA (Fig. 3, D, E, and H) . Interestingly, RT-qPCR measurements for Cldn10b revealed a five-fold (P Ͻ 0.05) increase in transcript levels in Hnf1␤-deficient cells (Fig. 3G) . Cldn10a expression levels were not detectable in the MKTAL cell line. Table 2) . Transfection of MKTAL cells with Hnf1␤ siRNAs resulted in no significant changes in cation permeability between the experimental and control conditions ( Table 2) .
Expression of Casr, Cldn19, and Cldn3 is regulated by HNF1␤ in vivo.
We confirmed our findings that HNF1␤ regulates CaSR transcription and, thereby, affects electrolyte reabsorption in the TAL by performing RT-qPCR on RNA isolated from kidney-specific (Ksp)-Cre;Hnf1␤ flox/flox mouse kidneys (n ϭ 3). In these mice, Ksp-cre-induced knockout of Hnf1␤ ensures that Hnf1␤ is inactivated in 99% of all TAL segments (38) . This specific lack of Hnf1␤ in the TAL causes a significant (P Ͻ 0.05) decrease of 81 Ϯ 6% in Casr mRNA abundance (Fig. 4A) . Cldn14, one of the critical downstream targets of the CaSR, was not significantly affected by the decrease in Casr abundance (Fig. 4B) . Similarly, Cldn16 mRNA levels were not significantly altered (Fig. 4C) . Contrary to the in vitro data (Fig. 3 , E and G), Cldn19 and Cldn10b were significantly downregulated by 37 Ϯ 6% and 83 Ϯ 2%, respectively, in Hnf1␤ mutant mice (Fig. 4, D and E) . Interestingly, Cldn3, a component of the divalent cation-selective pore in the TAL, exhibited a significant 4.6-fold increase in Hnf1␤ floxϩ/floxϩ mice compared with Hnf1␤ flox-/flox-mice (Fig. 4F ).
DISCUSSION
Our findings provide novel insights into the role of HNF1␤ in the TAL. HNF1␤ is ubiquitously expressed throughout the kidney (36) . Therefore, it is likely that problems with electrolyte homeostasis in ADTKD-HNF1␤ patients cannot be attrib- The CaSR is a G protein-coupled receptor (GPCR) that is sensitive to extracellular Ca 2ϩ , and, to a lesser extent, Mg 2ϩ ions (8, 32) . The receptor plays a major role in the maintenance of the plasma Ca 2ϩ concentration by regulating the circulating levels of parathyroid hormone and directly affecting Ca 2ϩ reabsorption in the kidney (35) . Intracellular signaling is initiated upon Ca 2ϩ binding to the large extracellular domain. CaSR-dependent signaling activates phospholipase C activity that results in an accumulation of inositol 1,4,5-trisphosphate and a rapid increase of the cytosolic Ca 2ϩ concentration (7, 9, 10). Although it has been shown that the CaSR promoter is responsive to 1,25-dihydroxyvitamin D 3 , proinflammatory cytokines, and the transcription factor glial cells missing-2 (GCM2), this is the first report of regulation of the CaSR by HNF1␤ (33).
The CaSR gene has eight exons, of which exons 2 to 7 contain the coding sequence for the CaSR protein (GenBank U20759). Interestingly, the gene harbors two alternative first exons (1A and 1B) that encode different 5=-UTRs, both splicing to the common exon 2 (12, 25) . The human CaSR gene has two promoters driving the transcription of alternative exons 1A and 1B. Our data demonstrated that HNF1␤ regulates promoter 1 activity, whereas promoter 2 is unaffected. The CaSR is highly expressed in the parathyroid gland and the renal tubular system, including the TAL (41) . Northern blot analysis of human parathyroid glands shows exclusive exon 1A use (12) . Moreover, nephrolithiasis is associated with the transcription of promoter 1 (49) . These data suggest that promoter 1-driven exon 1A transcription is most important for Ca 2ϩ and Mg 2ϩ transport. Therefore, HNF1␤-regulated promoter 1 activity may be of particular importance for renal electrolyte homeostasis.
In TAL, the CaSR has been implicated in the regulation of NKCC2 activity and CLDN14 expression (24, 28 . This reduces the expression of two miRNAs, Mir-9, and Mir-374. As a consequence of this downregulation, Cldn14 mRNA levels are decreased (28) . In our model, we expected to observe a decrease in Cldn14 due to the decreased CaSR activity following Hnf1␤-mediated downregulation. A decrease in Cldn14 expression was, indeed, observed in our MKTAL cell model, when Hnf1␤ expression was suppressed. However, there was no significant decrease in Cldn14 expression levels in Ksp-Cre;Hnf1␤ flox/flox mouse kidneys. Cldn14 expression is normally low in mice on a normal Ca 2ϩ diet (18, 29) ; previous studies have shown that an increase in dietary Ca 2ϩ is required to ensure Cldn14 upregulation (18, 27, 29, 43) . Our data confirm low basal expression levels of Cldn14. Previous research showed that wild-type mice treated with the CaSR agonist cinacalcet had increased expression of Cldn14 (28) . Subjecting HNF1␤ mutant mice to cinacalcet is not possible, as these mice suffer from early postnatal lethality, which limits any further investigation (30) . There are some disparities between the in vitro and in vivo expression levels of Cldn10b, Cldn19, and Cldn3 (Figs. 3, 
E, G, H and 4, D-F).
Although these discrepancies cannot completely be explained, it is expected that this is a limitation of the MKTAL cell model. It has recently been shown that the mosaic claudin expression in the TAL results in several types highly organized and spatially separated paracellular permeation pathways in vivo wild-type mice; *P Ͻ 0.05. (4, 42) . This complex physiological organization is not mimicked in MKTAL cells, which just express one type of paracellular shunt. Moreover, MKTAL cells cannot take into account the compensatory effects of other tubule segments affected by a reduction in HNF1␤. The ion permeability measurements performed in Ussing chambers displayed that MKTAL cells are not suitable for permeability studies, because the cells were not selective for Na ϩ , Mg 2ϩ , or Ca 2ϩ ( Table 2 ). The P Na /P Cl values did not exceed 1.2, whereas cortical TAL and medullary TAL should have at least a P Na /P Cl of around 4 and 8, respectively to accurately mimic the ion transport selectivity in these segments in vivo (4) . Furthermore, targeting HNF1␤ expression in MKTAL cells did not elicit the expected decrease in Na ϩ and increase in Mg 2ϩ and Ca 2ϩ permeability. Taken together, our experiments indicate that the MKTAL cell line is not a sufficient model to study ion transport.
Patients that suffer from ADTKD-HNF1␤ often have kidney cyst formation (20, 46) . A study in mice with rodent nephronophthisis shows that stimulating the CaSR with calcimimetics reduced cyst progression (11) . A lack of CaSR expression due to an HNF1␤ mutation might contribute to cyst formation. It would, therefore, be interesting to treat ADTKD-HNF1␤ patients with calcimimetics to induce CaSR activity and reduce cyst progression. In some cases, ADTKD-HNF1␤ patients develop nephrolithiasis (21) . Curiously, a single-nucleotide polymorphism (SNP) in the CaSR promoter 1 has been associated with nephrolithiasis (49) . The SNP was more frequent in stone formers vs. controls, and homozygous SNP carriers had lower CaSR mRNA levels in the kidney medulla (49) . Our finding that HNF1␤ controls CaSR transcription may, therefore, be of clinical interest for reducing cyst and kidney stone formation. However, more research is needed to elucidate what effect the loss of HNF1␤ has on ion transport in the TAL and what the consequences are for the ADTKD-HNF1␤ patient.
In conclusion, an HNF1␤ binding site was identified in the second intron of the CaSR gene. Our data indicate that HNF1␤ positively regulates gene transcription of the CaSR in vitro and in vivo, thereby providing a novel insight into the potential role of HNF1␤ in electrolyte transport that is not only confined to the DCT, but also relevant to TAL function.
